Associated Papers
Reanalysis of Trio Whole-Genome Sequencing Data Doubles the Yield in Autism Spectrum Disorder: De Novo Variants Present in Half.
Bar O et al.
International Journal of Molecular Sciences, 2024
38256266 (PubMed )
Supplement: ijms-25-01192-s001.zip › ijms-2816629-supplementary.xlsx › Table_S5
Advances in neurexin studies and the emerging role of neurexin-2 in autism spectrum disorder.
Khoja S et al.
Frontiers in Molecular Neuroscience, 2023
36923655 (PubMed )
Supplement: Table_1.XLSX › NRXN1
Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders.
Wang T et al.
Nature Communications, 2020
33004838 (PubMed )
Supplement: 41467_2020_18723_MOESM6_ESM.xlsx › Supplementary_Data_4
Functional characterization of rare NRXN1 variants identified in autism spectrum disorders and schizophrenia.
Ishizuka K et al.
Journal of Neurodevelopmental Disorders, 2020
Genomic and molecular characterization of esophageal squamous cell carcinoma.
Lin DC et al.
Nature Genetics, 2014
24686850 (PubMed )
Supplement: NIHMS573166-supplement-9.xlsx › Supplementary_Table_6
Select a paper to view details